Issue: Vol. 5, No. 11 - August 24, 2018
Go Back to Medtech Strategist Issue Archive
Table of Contents – MedTech Strategist, Vol. 5, No. 11, August 24, 2018 (56 Pages):
“From the Community Blog,” by the MedTech Strategist Team
Perspective – “As the Digital Revolution Sweeps Healthcare, Don’t Shortchange IVD,” by Wendy Diller
3D Manufacturing – “Carbon: Bringing a Revolution to the 3D Revolution,” by David Cassak
– Sidebar: “A Play for Johnson & Johnson,” by David Cassak
Electrophysiology – “Atrial Fibrillation Ablation After CABANA: What Are We Missing?” by Mary Stuart
– Sidebar: “CABANA Results in Confusion, Not Clarity,” by Mary Stuart
Quick Take: AI and Stroke – “Companies See Big Opportunity for AI-Assisted Imaging in Stroke,” by Varun Saxena
M&A/Financing Review – “Medtech US IPO Window Finally Re-opens; Financial Buyers Return to M&A Market,” by Stephen Levin
Start-Ups To Watch – “AblaCare: Infertility Treatment Made Safer,” by Colin Miller
Start-Ups To Watch – “Carmentix: A Biomarker-Based Approach to the Global Problem of Preterm Births,” by Mary Stuart